Benzyl 3,5-dioxopiperidine-1-carboxylate → HCID 136242923、化合物
反応式
Br[C:2]1[C:11]([NH2:12])=[CH:10][C:9]([F:13])=[CH:8][C:3]=1[C:4]([O:6]C)=O.O=C1CC(=O)CN(C(OCC2C=CC=CC=2)=O)C1.[CH3:32][N:33]1[CH2:45][C:44]2NC3C=CC=C4C(=O)[NH:47][N:48]=[C:35]([C:36]=2C=34)[CH2:34]1>>[F:13][C:9]1[CH:8]=[C:3]2[C:4](=[O:6])[NH:47][N:48]=[C:35]3[C:36]4[C:2]2=[C:11]([NH:12][C:44]=4[CH2:45][N:33]([CH3:32])[CH2:34]3)[CH:10]=1参加物
4
実験手順
Compound 55 was prepared from methyl 2-bromo-5-fluoro-3-aminobenzoate and benzyl 3,5-dioxopiperidine-1-carboxylate according to the procedures similar to those for Compound 44. 1H NMR (DMSO-d6) δ 11.9 (s, 1H), 10.1 (s, 1H), 7.36 (dd, 1H, J=1.8, 9.6 Hz), 7.20 (dd, 1H, J=1.8, 10.2 Hz), 3.75 (s, 2H), 3.24 (s, 2H), 2.44 (s, 3H). MS (ESI) m/e [M+1]+ 259.
出典と根拠
- ORDレコード
- ord-0b72db669a154aa485f8d1bfd6ba0bd9